Brookline, MA, United States of America

Kettner John Frederick Griswold, Jr

This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignees: Harvard College, The Charles Stark Draper Laboratory, Inc.. Active years: 2020-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kettner John Frederick Griswold, Jr. Retrieved from https://idiyas.com/inventor/kettner-john-frederick-griswold-jr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 2.8

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2023

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovator Kettner John Frederick Griswold, Jr. - A Pioneer in Nucleotide Analog Research

Introduction

Kettner John Frederick Griswold, Jr. is a notable inventor based in Brookline, Massachusetts, recognized for his significant contributions to the field of nucleotide analogs. With three patents to his name, Kettner's work focuses on advancing molecular chain synthesis and enhancing DNA sequencing technologies.

Latest Patents

Griswold's latest patents showcase his innovative approach to biochemistry. His first patent, "Cleavable nucleotide analogs and uses thereof," introduces nucleotide analogs that incorporate a cleavable moiety. This moiety facilitates the restoration of a free 3'-OH functional group during DNA sequencing by synthesis, allowing for the growth of polynucleotide molecules. The invention emphasizes the versatility of these nucleotide analogs in utilizing template-independent polymerases.

Another impressive patent is "Composition for use in molecular chain synthesis." This composition comprises a carrier group and a payload group, where the carrier group includes a signaling group and a blocking group. The selective cleavability of the bonds ensures precision in molecular chain extensions, crucial for advanced scientific applications. The signaling group is designed to emit a signature photon, enhancing the interrogation processes in biochemical research.

Career Highlights

Kettner has worked with prestigious institutions, including Harvard College and the Charles Stark Draper Laboratory, Inc. His experience at these organizations reflects his dedication to advancing scientific knowledge through innovation.

Collaborations

Throughout his career, Kettner has collaborated with influential scientists such as George M. Church and Melissa M. Sprachman. These partnerships have played a significant role in the development and enhancement of Kettner's groundbreaking research.

Conclusion

Kettner John Frederick Griswold, Jr. stands out as a distinguished inventor in the realm of nucleotide analogs. His patents not only embody innovation but also contribute to the broader scientific community's understanding of DNA synthesis and molecular chain processes. As Kettner continues to explore the frontiers of biochemistry, his work paves the way for future advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…